BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©Author(s) (or their employer(s)) 2026.
World J Gastrointest Surg. Feb 27, 2026; 18(2): 115902
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.115902
Table 2 Univariate analysis of risk factors for colorectal adenomatous polyps, n (%)
Clinical data
Colorectal adenomatous polyp group (n = 75)
Non-colorectal adenomatous polyp group (n = 127)
χ2 or t value
P value
Age20.054< 0.001
< 60 years24 (32.00)82 (64.57)
≥ 60 years51 (68.00)45 (35.43)
Sex0.0610.806
Male40 (53.33)70 (55.12)
Female35 (46.67)57 (44.88)
Smoking10.1290.001
No24 (32.00)70 (55.12)
Yes51 (68.00)57 (44.88)
Drinking13.467< 0.001
No31 (41.33)86 (67.72)
Yes44 (58.67)41 (32.28)
Underlying disease
Hypertension10 (13.33)21 (16.54)0.3720.542
Diabetes18 (24.00)23 (18.11)2.1430.143
Coronary heart disease25 (33.33)36 (28.35)0.5560.456
Hyperlipidemia13 (17.33)20 (15.75)0.0870.768
Fatty liver46 (61.33)37 (29.13)20.197< 0.001
Gallbladder polyp38 (50.67)22 (17.32)25.108< 0.001
Family history of malignancy0.0940.342
No18 (24.00)27 (21.26)
Yes47 (76.00)100 (78.74)
HbA1c14.993< 0.001
Normal15 (20.00)60 (47.24)
Abnormal60 (80.00)67 (52.76)
LDL-C (mmol/L), mean ± SD2.71 ± 0.302.79 ± 0.321.7570.081
HDL-C (mmol/L), mean ± SD1.26 ± 0.211.20 ± 0.241.7960.074
TG (mmol/L), mean ± SD1.40 ± 0.261.35 ± 0.261.3210.188
TC (mmol/L), mean ± SD4.47 ± 0.584.50 ± 0.510.3840.702


Write to the Help Desk